Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Elevated myonuclear density during skeletal muscle hypertrophy in response to training is reversed during detraining.

Dungan CM, Murach KA, Frick KK, Jones SR, Crow SE, Englund DA, Vechetti IJ Jr, Figueiredo VC, Levitan BM, Satin J, McCarthy JJ, Peterson CA.

Am J Physiol Cell Physiol. 2019 May 1;316(5):C649-C654. doi: 10.1152/ajpcell.00050.2019. Epub 2019 Mar 6.

PMID:
30840493
2.

Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.

Krieger NS, Grynpas M, VandenEynde A, Asplin JR, Frick KK, Kim MH, Ramos FM, Granja I, Bushinsky DA.

Nephron. 2019;142(2):147-158. doi: 10.1159/000497117. Epub 2019 Feb 6.

PMID:
30726853
3.

Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

Frick KK, Krieger NS, Bushinsky DA.

Curr Opin Nephrol Hypertens. 2015 Jul;24(4):336-44. doi: 10.1097/MNH.0000000000000130. Review.

4.

Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA.

J Am Soc Nephrol. 2015 Dec;26(12):3001-8. doi: 10.1681/ASN.2014121223. Epub 2015 Apr 8.

5.

Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Frick KK, Asplin JR, Culbertson CD, Granja I, Krieger NS, Bushinsky DA.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F1081-7. doi: 10.1152/ajprenal.00680.2013. Epub 2014 Feb 26.

6.

1,25(OH)ā‚‚Dā‚ƒ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.

Ng AH, Frick KK, Krieger NS, Asplin JR, Cohen-McFarlane M, Culbertson CD, Kyker-Snowman K, Grynpas MD, Bushinsky DA.

Calcif Tissue Int. 2014 May;94(5):531-43. doi: 10.1007/s00223-014-9838-7. Epub 2014 Jan 31.

7.

1,25(OH)ā‚‚Dā‚ƒ-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Frick KK, Asplin JR, Krieger NS, Culbertson CD, Asplin DM, Bushinsky DA.

Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1132-8. doi: 10.1152/ajprenal.00296.2013. Epub 2013 Aug 7.

8.

Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.

Frick KK, Asplin JR, Favus MJ, Culbertson C, Krieger NS, Bushinsky DA.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F718-26. doi: 10.1152/ajprenal.00645.2012. Epub 2013 Jan 23.

9.

Effect of metabolic and respiratory acidosis on intracellular calcium in osteoblasts.

Frick KK, Bushinsky DA.

Am J Physiol Renal Physiol. 2010 Aug;299(2):F418-25. doi: 10.1152/ajprenal.00136.2010. Epub 2010 May 26.

10.

Metabolic acidosis increases intracellular calcium in bone cells through activation of the proton receptor OGR1.

Frick KK, Krieger NS, Nehrke K, Bushinsky DA.

J Bone Miner Res. 2009 Feb;24(2):305-13. doi: 10.1359/jbmr.081015.

11.

Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro.

Krieger NS, Frick KK, LaPlante Strutz K, Michalenka A, Bushinsky DA.

J Bone Miner Res. 2007 Jun;22(6):907-17.

12.

Genetic hypercalciuric stone-forming rats.

Bushinsky DA, Frick KK, Nehrke K.

Curr Opin Nephrol Hypertens. 2006 Jul;15(4):403-18. Review.

PMID:
16775455
13.

RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro.

Frick KK, LaPlante K, Bushinsky DA.

Am J Physiol Renal Physiol. 2005 Nov;289(5):F1005-11. Epub 2005 Jun 21.

14.

Mechanism of acid-induced bone resorption.

Krieger NS, Frick KK, Bushinsky DA.

Curr Opin Nephrol Hypertens. 2004 Jul;13(4):423-36. Review.

PMID:
15199293
15.

Cellular mechanisms of bone resorption induced by metabolic acidosis.

Krieger NS, Bushinsky DA, Frick KK.

Semin Dial. 2003 Nov-Dec;16(6):463-6. Review.

PMID:
14629607
16.
17.

Molecular mechanisms of primary hypercalciuria.

Frick KK, Bushinsky DA.

J Am Soc Nephrol. 2003 Apr;14(4):1082-95. Review. No abstract available.

18.

Cortisol inhibits acid-induced bone resorption in vitro.

Krieger NS, Frick KK, Bushinsky DA.

J Am Soc Nephrol. 2002 Oct;13(10):2534-9.

19.

Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.

Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.

Cancer Res. 2001 Feb 1;61(3):1073-9.

20.

The effects of acid on bone.

Bushinsky DA, Frick KK.

Curr Opin Nephrol Hypertens. 2000 Jul;9(4):369-79. Review.

PMID:
10926173
21.

In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression.

Frick KK, Bushinsky DA.

Am J Physiol. 1999 Nov;277(5):F750-5. doi: 10.1152/ajprenal.1999.277.5.F750.

PMID:
10564238
22.

Chronic metabolic acidosis reversibly inhibits extracellular matrix gene expression in mouse osteoblasts.

Frick KK, Bushinsky DA.

Am J Physiol. 1998 Nov;275(5):F840-7. doi: 10.1152/ajprenal.1998.275.5.F840.

PMID:
9815143
23.

Acute metabolic acidosis inhibits the induction of osteoblastic egr-1 and type 1 collagen.

Frick KK, Jiang L, Bushinsky DA.

Am J Physiol. 1997 May;272(5 Pt 1):C1450-6.

PMID:
9176134
24.

Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.

Furlanetto RW, Harwell SE, Frick KK.

Mol Endocrinol. 1994 Apr;8(4):510-7.

PMID:
8052269
25.

Steady-state mRNA expression for growth factors in DMBA-induced rat mammary tumors.

Ruggeri BA, Klurfeld DM, Kritchevsky D, Frick KK.

Cancer Lett. 1990 Dec 3;55(2):89-93.

PMID:
2124948
27.
28.
29.

Cloning of immunity and structural genes for colicin V.

Frick KK, Quackenbush RL, Konisky J.

J Bacteriol. 1981 Nov;148(2):498-507.

Supplemental Content

Loading ...
Support Center